Astera Labs (NASDAQ:ALAB) Trading Down 3.1% – Time to Sell?

Astera Labs, Inc. (NASDAQ:ALAB) fell 3.1% during mid-day trading on Monday . The stock traded as low as $267.74 and last traded at $282.52. 4,100,365 shares traded hands during mid-day trading, a decline of 26% from the average daily volume of 5,538,956 shares. The stock had previously closed at $291.58.

Wall Street Analyst Weigh In

ALAB has been the topic of several recent analyst reports. Jefferies Financial Group reiterated a “buy” rating and issued a $270.00 price target on shares of Astera Labs in a report on Wednesday, May 6th. JPMorgan Chase & Co. upped their price objective on Astera Labs from $205.00 to $280.00 and gave the company an “overweight” rating in a research report on Wednesday, May 6th. Rothschild & Co Redburn initiated coverage on Astera Labs in a research note on Friday, May 1st. They issued a “neutral” rating and a $153.00 target price on the stock. Citigroup reiterated a “buy” rating on shares of Astera Labs in a report on Wednesday. Finally, Weiss Ratings upgraded shares of Astera Labs from a “hold (c-)” rating to a “hold (c)” rating in a research note on Thursday, May 21st. Thirteen equities research analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the company. According to data from MarketBeat.com, Astera Labs currently has a consensus rating of “Moderate Buy” and a consensus target price of $282.00.

Astera Labs Stock Down 4.9%

The stock’s 50 day moving average is $360.60 and its two-hundred day moving average is $227.59. The company has a market capitalization of $42.43 billion, a PE ratio of 166.77, a price-to-earnings-growth ratio of 3.27 and a beta of 3.66.

Astera Labs (NASDAQ:ALAB) last issued its earnings results on Tuesday, May 5th. The company reported $0.61 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.54 by $0.07. Astera Labs had a net margin of 26.72% and a return on equity of 18.49%. The company had revenue of $308.36 million for the quarter, compared to analysts’ expectations of $292.19 million. During the same period in the prior year, the business earned $0.33 EPS. The firm’s quarterly revenue was up 93.5% on a year-over-year basis. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. On average, sell-side analysts predict that Astera Labs, Inc. will post 1.86 EPS for the current fiscal year.

Insider Activity

In related news, Director Manuel Alba sold 136,974 shares of the company’s stock in a transaction on Wednesday, July 1st. The stock was sold at an average price of $442.01, for a total transaction of $60,543,877.74. Following the completion of the sale, the director directly owned 1,287,524 shares in the company, valued at $569,098,483.24. This represents a 9.62% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Jitendra Mohan sold 139,951 shares of the stock in a transaction dated Thursday, May 7th. The shares were sold at an average price of $200.16, for a total transaction of $28,012,592.16. Following the sale, the chief executive officer directly owned 3,929,183 shares of the company’s stock, valued at approximately $786,465,269.28. The trade was a 3.44% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders have sold 1,676,845 shares of company stock worth $444,928,806. Corporate insiders own 10.40% of the company’s stock.

Institutional Trading of Astera Labs

Several hedge funds and other institutional investors have recently made changes to their positions in the business. Reflection Asset Management purchased a new position in shares of Astera Labs in the 4th quarter valued at approximately $25,000. Smartleaf Asset Management LLC increased its holdings in shares of Astera Labs by 422.2% in the fourth quarter. Smartleaf Asset Management LLC now owns 188 shares of the company’s stock valued at $32,000 after purchasing an additional 152 shares during the period. Towarzystwo Funduszy Inwestycyjnych PZU SA purchased a new position in shares of Astera Labs in the fourth quarter worth about $33,000. Whipplewood Advisors LLC raised its position in Astera Labs by 15,950.0% during the 1st quarter. Whipplewood Advisors LLC now owns 321 shares of the company’s stock worth $35,000 after buying an additional 319 shares during the last quarter. Finally, Assetmark Inc. raised its holdings in shares of Astera Labs by 78.9% during the fourth quarter. Assetmark Inc. now owns 229 shares of the company’s stock worth $38,000 after purchasing an additional 101 shares during the last quarter. Hedge funds and other institutional investors own 60.47% of the company’s stock.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.